282 related articles for article (PubMed ID: 36040683)
1. Methyltransferase-like 3 (METTL3) mediated N6-methyladenosine (m6A) modifications facilitate mir-25-3p maturation to promote gastrointestinal stromal tumors (GISTs) progression.
Qian K; Xu W; Xia X; Ding J
Genes Genomics; 2022 Dec; 44(12):1519-1530. PubMed ID: 36040683
[TBL] [Abstract][Full Text] [Related]
2. METTL3 m6A-dependently promotes miR-21-5p maturation to accelerate choriocarcinoma progression via the HIF1AN-induced inactivation of the HIF1A/VEGF pathway.
Ye K; Li L; Wu B; Wang D
Genes Genomics; 2022 Nov; 44(11):1311-1322. PubMed ID: 36074324
[TBL] [Abstract][Full Text] [Related]
3. METTL3-mediated m6A modification promotes processing and maturation of
Gong Y; Jiang Q; Liu L; Liao Q; Yu J; Xiang Z; Luo X
Physiol Genomics; 2022 Sep; 54(9):337-349. PubMed ID: 35759451
[TBL] [Abstract][Full Text] [Related]
4. METTL3-mediated m6A modification of pri-miR-148a-3p affects prostate cancer progression by regulating TXNIP.
Li G; Liu J; Wang Y; Liu H; Fu J; Zhao Y; Huang Y
Environ Toxicol; 2023 Oct; 38(10):2377-2390. PubMed ID: 37449729
[TBL] [Abstract][Full Text] [Related]
5. Methyltransferase-like 3 facilitates lung cancer progression by accelerating m6A methylation-mediated primary miR-663 processing and impeding SOCS6 expression.
Li S; Lu X; Zheng D; Chen W; Li Y; Li F
J Cancer Res Clin Oncol; 2022 Dec; 148(12):3485-3499. PubMed ID: 35907010
[TBL] [Abstract][Full Text] [Related]
6. m6A-mediated lncRNA NEAT1 plays an oncogenic role in non-small cell lung cancer by upregulating the HMGA1 expression through binding miR-361-3p.
Qi L; Yin Y; Sun M
Genes Genomics; 2023 Dec; 45(12):1537-1547. PubMed ID: 37688756
[TBL] [Abstract][Full Text] [Related]
7. The m6A Methyltransferase METTL3-Mediated N6-Methyladenosine Modification of DEK mRNA to Promote Gastric Cancer Cell Growth and Metastasis.
Zhang HM; Qi FF; Wang J; Duan YY; Zhao LL; Wang YD; Zhang TC; Liao XH
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742899
[TBL] [Abstract][Full Text] [Related]
8. Circular RNA circ_KIAA1429 accelerates hepatocellular carcinoma progression via the miR-133a-3p/high mobility group AT-hook 2 (HMGA2) axis in an m6A-dependent manner.
Zhang CP; Huang XY
Hum Cell; 2023 Sep; 36(5):1741-1754. PubMed ID: 37368192
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of METTL3-mediated m6A modification in depression-induced cognitive deficits.
Niu J; Wang B; Wang T; Zhou T
Am J Med Genet B Neuropsychiatr Genet; 2022 Apr; 189(3-4):86-99. PubMed ID: 35591810
[TBL] [Abstract][Full Text] [Related]
10. miR-302a-3p suppresses melanoma cell progression via targeting METTL3.
Chang X; Lin YY; Bai LN; Zhu W
J Chemother; 2022 Feb; 34(1):55-66. PubMed ID: 34286671
[TBL] [Abstract][Full Text] [Related]
11. METTL3-Induced miR-222-3p Upregulation Inhibits STK4 and Promotes the Malignant Behaviors of Thyroid Carcinoma Cells.
Lin S; Zhu Y; Ji C; Yu W; Zhang C; Tan L; Long M; Luo D; Peng X
J Clin Endocrinol Metab; 2022 Jan; 107(2):474-490. PubMed ID: 34562008
[TBL] [Abstract][Full Text] [Related]
12. Cross talk between RNA N6-methyladenosine methyltransferase-like 3 and miR-186 regulates hepatoblastoma progression through Wnt/β-catenin signalling pathway.
Cui X; Wang Z; Li J; Zhu J; Ren Z; Zhang D; Zhao W; Fan Y; Zhang D; Sun R
Cell Prolif; 2020 Mar; 53(3):e12768. PubMed ID: 31967701
[TBL] [Abstract][Full Text] [Related]
13. N(6)-methyladenosine-mediated miR-380-3p maturation and upregulation promotes cancer aggressiveness in pancreatic cancer.
Jiang Z; Song X; Wei Y; Li Y; Kong D; Sun J
Bioengineered; 2022 Jun; 13(6):14460-14471. PubMed ID: 35758158
[TBL] [Abstract][Full Text] [Related]
14. N6-methyladenosine-modified microRNA-675 advances the development of gastrointestinal stromal tumors via inhibiting myosin phosphatase targeting protein 1.
Ling X; Wang R; Lin L; Wu Y; Cheng W
Genomics; 2023 Sep; 115(5):110704. PubMed ID: 37678441
[TBL] [Abstract][Full Text] [Related]
15. METTL3 promotes prostate cancer progression by regulating miR-182 maturation in m6A-dependent manner.
Wang D; Wang X; Huang B; Zhao Y; Tu W; Jin X; Shao Y; Zhu Y; Lu G
Andrologia; 2022 Aug; 54(7):1581-1591. PubMed ID: 35413135
[TBL] [Abstract][Full Text] [Related]
16. Silencing METTL3 Stabilizes Atherosclerotic Plaques by Regulating the Phenotypic Transformation of Vascular Smooth Muscle Cells via the miR-375-3p/PDK1 Axis.
Chen J; Lai K; Yong X; Yin H; Chen Z; Wang H; Chen K; Zheng J
Cardiovasc Drugs Ther; 2023 Jun; 37(3):471-486. PubMed ID: 35704246
[TBL] [Abstract][Full Text] [Related]
17. METTL3 regulates N6-methyladenosine modification of ANGPTL3 mRNA and potentiates malignant progression of stomach adenocarcinoma.
Zhang Z; Fu J; Zhang Y; Qin X; Wang Y; Xing C
BMC Gastroenterol; 2023 Jun; 23(1):217. PubMed ID: 37344779
[TBL] [Abstract]